A Cochrane systematic review of 22 randomized trials involving 1,995 adults with overweight or obesity found intermittent ...

Women and the middle classes are dominating take-up of weight loss injections, research suggests. Analysis of private ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In fact, a recent poll finds 1 in 8 adults are now ...

Eli Lilly aims to establish India as a key hub for its global supply chain. The company plans to export drugs manufactured ...

Mounjaro-maker Eli Lilly wants to turn India into a hub for its global supply chain, a senior executive at the U.S. drugmaker said, as ...

A new study shows that people are likely to continue taking GLP-1 drugs like Ozempic, which is commonly prescribed off-label ...

Researchers report that intermittent fasting is no more effective for weight loss than other dietary routines. Experts say ...

Compared to traditional dietary advice (like restricting calories or eating different types of foods), intermittent fasting may make little to no difference to weight loss and quality of life in ...

Scientists have discovered a brain signaling pathway that eliminates body fat without reducing food intake by targeting ...

Obesity is not just about appearance it is a serious medical condition. At Sahitya Aaj Tak Lucknow 2026, leading doctors explained the science behind weight gain and diabetes.

Women's health expert Dr. Mary Claire Haver reveals three essential changes for healthy aging: sleep, proper nutrition and ...

Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug ahead of an expected decision by the U.S. Food and Drug Administration in April, Reuters writes, ...